News
A new understanding of how tumours exploit our nervous system is leading to new ways to treat cancer using familiar drugs ...
Discover why nails separate from the nail bed, what causes onycholysis, and how to treat this common but concerning nail ...
Eric Winer, a breast cancer specialist who directs the Yale Cancer Center, cited Taxol as “certainly one of the top three chemotherapy drugs that have ever been ... a dauntingly complex molecule with ...
The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation ...
Although structure-based drug discovery is still in its infancy ... The modern era of antibacterial chemotherapy began in the 1930s, and the next four decades saw the discovery of almost all ...
Anlotinib plus chemotherapy demonstrated similar efficacy as bevacizumab plus chemotherapy for certain patients with ...
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with ...
The first to receive US Food and Drug Administration (FDA ... resembling the natural T-cell receptor (TCR) structure, ...
Rising brain tumor cases in India, with advanced imaging techniques and treatment options offering hope for better outcomes.
Bayer blockbuster Nubeqa receives US FDA approval for patients with advanced prostate cancer: Berlin Thursday, June 5, 2025, 13:00 Hrs [IST] Bayer announced that the US Food and D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results